[Differential effects of GnRH analogs on androgen concentrations in females].
Wirth
U
U
Univers.-Frauenklinik Ulm/Donau.
Rossmanith
W G
WG
Sasse
V
V
Lauritzen
C
C
D000328:Adult; D000728:Androgens / Q000097:blood*; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D002064:Buserelin / Q000008:administration & dosage / Q000031:analogs & derivatives*; D004343:Drug Implants; D004715:Endometriosis / Q000097:blood* / Q000628:therapy*; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood; D007987:Gonadotropin-Releasing Hormone / Q000008:administration & dosage / Q000031:analogs & derivatives*; D017273:Goserelin; D006801:Humans; D007273:Injections, Intramuscular; D007889:Leiomyoma / Q000097:blood* / Q000628:therapy*; D007986:Luteinizing Hormone / Q000097:blood; D017329:Triptorelin Pamoate; D014594:Uterine Neoplasms / Q000097:blood* / Q000628:therapy*
D000728:Androgens; D000970:Antineoplastic Agents; D004343:Drug Implants; D017329:Triptorelin Pamoate; D017273:Goserelin; D007987:Gonadotropin-Releasing Hormone; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D002064:Buserelin
Unterschiedliche Wirkungen von GnRH-Analogen auf die Androgenkonzentrationen bei Frauen.